MedPath

Analysis of prognosis of patients who were treated with oral immunotherapy.

Not Applicable
Conditions
Food Allergy
Registration Number
JPRN-UMIN000018179
Lead Sponsor
ational Hospital Organization Sagamihara National Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
500
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who did not agree to participate in the study.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Rate of patients who experienced allergic reactions after completing oral immunotherapy.
Secondary Outcome Measures
NameTimeMethod
1.Rate of patients who used adrenaline self-injector. 2.Consumption frequency of tolerated foods. 3.Consumption of tolerated foods with or without reluctance. 4.Consumption of tolerated foods and allergic reactions experienced at school.
© Copyright 2025. All Rights Reserved by MedPath